Amphastar Pharmaceuticals, Inc.

US$28.49As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:AMPHHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR 4.61%
Div yield —
ROE 12.44%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.94
PE TTM 13.08
TSR TTM 11.73%
Mkt cap US$1.215B
ROIC 8.74%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$32
13.70%
(49.55%)
Hold 11|8|1|0|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.34
0.38
0.42
0.44
8.00%
14.46%
18.57%
28.59%
Revenue$M
95.31
92.87
93.04
97.61
6.30%
2.43%
(0.73%)
5.57%
Peers (US$1.215B)
Cap (US$)
PE
1.461B
39.91x
1.428B
13.47x
1.208B
35.03x
Capital
TTM
5Y
10Y
Leveragex
2.551
(0.011)
—
EBIT/Intx
0.845
0.430
0.393
Own earn%
(55.64)
(120.08)
(114.53)
Sh yield%
38.81
37.03
34.20
Owners
Insiders/Inst%
8.11
54.25
Short interest%
5.39
SBC / revenue%
5.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
12–20
$1 testx
—
Incr. ROIC%
125